ISARIC researchers have published a new review outlining the key clinical characteristics and pathogenesis of Nipah virus disease. The review, which has been published in The Lancet Microbe, addresses critical knowledge gaps, helping to inform the design of future clinical trials and improve patient treatment.

A new set of guidelines developed through ISARIC, the University of Oxford Pandemic Sciences Institute, and Global Outbreak and Response Network (GOARN) provides outbreak response teams with evidence-based strategies to recognise and reduce stigma. The ISARIC Anti-Stigma Guidelines are now available open access to all organisations working to improve equity and trust in global outbreak management globally.

A major international collaboration between ISARIC researchers at King’s College London and the Oxford University Clinical Research Trials Unit (OUCRU) has created the first global Core Outcome Measurement Set (COMS) for dengue clinical trials.